Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology
Free Medical Books

  Bladder Cancer

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    November 2011
  1. RAMACHANDRAN K , Gordian E, Singal R
    5-azacytidine reverses drug resistance in bladder cancer cells.
    Anticancer Res. 2011;31:3757-66.
    PubMed     Text format     Related articles    Abstract available



    October 2011
  2. DU P , Ye L, Ruge F, Yang Y, et al
    Metastasis Suppressor-1, MTSS1, Acts as a Putative Tumour Suppressor in Human Bladder Cancer.
    Anticancer Res. 2011;31:3205-12.
    PubMed     Text format     Related articles    Abstract available



    June 2011
  3. MIYATA Y , Sagara Y, Matsuo T, Ohba K, et al
    Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature review.
    Anticancer Res. 2011;31:2335-8.
    PubMed     Text format     Related articles    Abstract available



  4. MIYAZAKI J , Nishiyama H, Yano I, Nakaya A, et al
    The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma.
    Anticancer Res. 2011;31:2065-71.
    PubMed     Text format     Related articles    Abstract available



    May 2011
  5. VASCONCELOS-NOBREGA C , Colaco A, Santos L, Vala H, et al
    Experimental study of the anticancer effect of gemcitabine combined with sirolimus on chemically induced urothelial lesions.
    Anticancer Res. 2011;31:1637-42.
    PubMed     Text format     Related articles    Abstract available



    April 2011
  6. ONISHI T , Sasaki T, Hoshina A, Yabana T, et al
    Continuous saline bladder irrigation after transurethral resection is a prophylactic treatment choice for non-muscle invasive bladder tumor.
    Anticancer Res. 2011;31:1471-4.
    PubMed     Text format     Related articles    Abstract available



    March 2011
  7. KRAUSE FS , Walter B, Ott OJ, Haberle L, et al
    15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment.
    Anticancer Res. 2011;31:985-90.
    PubMed     Text format     Related articles    Abstract available



  8. HOU JC , Landas S, Wang CY, Shapiro O, et al
    Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: an animal model.
    Anticancer Res. 2011;31:929-32.
    PubMed     Text format     Related articles    Abstract available



    February 2011
  9. CHARACIEJUS D , Pasukoniene V, Jacobs JJ, Eidukevicius R, et al
    Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2.
    Anticancer Res. 2011;31:699-703.
    PubMed     Text format     Related articles    Abstract available



    January 2011
  10. BRUNOCILLA E , Pernetti R, Martorana G
    The role of pelvic lymph node dissection during radical cystectomy for bladder cancer.
    Anticancer Res. 2011;31:271-5.
    PubMed     Text format     Related articles    Abstract available



    December 2010
  11. HEGELE A , Mecklenburg V, Varga Z, Olbert P, et al
    CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.
    Anticancer Res. 2010;30:5195-200.
    PubMed     Text format     Related articles    Abstract available



    November 2010
  12. MAFFEZZINI M , Campodonico F, Capponi G, Canepa G, et al
    Prognostic Significance of Fluorescent In Situ Hybridisation in the Follow-up of Non-muscle-invasive Bladder Cancer.
    Anticancer Res. 2010;30:4761-5.
    PubMed     Text format     Related articles    Abstract available



  13. POUESSEL D , Huguet H, Iborra F, Rebillard X, et al
    A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer.
    Anticancer Res. 2010;30:4711-5.
    PubMed     Text format     Related articles    Abstract available



  14. WANG S , Zhang H, Cheng L, Evans C, et al
    Analysis of the cytotoxic activity of carboplatin and gemcitabine combination.
    Anticancer Res. 2010;30:4573-8.
    PubMed     Text format     Related articles    Abstract available



  15. SUZUKI T , Terao S, Acharya B, Naoe M, et al
    The antitumour effect of {gamma}{delta} T-cells is enhanced by valproic acid-induced up-regulation of NKG2D ligands.
    Anticancer Res. 2010;30:4509-13.
    PubMed     Text format     Related articles    Abstract available



    October 2010
  16. KATO T , Bilim V, Yuuki K, Naito S, et al
    Bacillus Calmette-Guerin and BCG Cell Wall Skeleton Suppressed Viability of Bladder Cancer Cells In Vitro.
    Anticancer Res. 2010;30:4089-96.
    PubMed     Text format     Related articles    Abstract available



  17. AALTONEN V , Peltonen J
    PKCalpha/beta I inhibitor Go6976 induces dephosphorylation of constitutively hyperphosphorylated Rb and G1 arrest in T24 cells.
    Anticancer Res. 2010;30:3995-9.
    PubMed     Text format     Related articles    Abstract available



    September 2010
  18. TANJI N , Fukumoto T, Miura N, Yanagihara Y, et al
    Combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas in patients 80 years of age and over.
    Anticancer Res. 2010;30:3839-43.
    PubMed     Text format     Related articles    Abstract available



    July 2010
  19. PALMIERI F , Brunocilla E, Bertaccini A, Guidi M, et al
    Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.
    Anticancer Res. 2010;30:2973-6.
    PubMed     Text format     Related articles    Abstract available



  20. KIM H , Kang JW, Lee S, Choi WJ, et al
    A3 Adenosine Receptor Antagonist, Truncated Thio-Cl-IB-MECA, Induces Apoptosis in T24 Human Bladder Cancer Cells.
    Anticancer Res. 2010;30:2823-2830.
    PubMed     Text format     Related articles    Abstract available



    June 2010
  21. MIYAKE M , Fujimoto K, Anai S, Ohnishi S, et al
    Inhibition of heme oxygenase-1 enhances the cytotoxic effect of gemcitabine in urothelial cancer cells.
    Anticancer Res. 2010;30:2145-52.
    PubMed     Text format     Related articles    Abstract available



    January 2010
  22. ZHANG N , Sanders AJ, Ye L, Kynaston HG, et al
    Expression of Vascular Endothelial Growth Inhibitor (VEGI) in Human Urothelial Cancer of the Bladder and its Effects on the Adhesion and Migration of Bladder Cancer Cells In Vitro.
    Anticancer Res. 2010;30:87-95.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: